Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse - PubMed
. 2015 Nov;141(11):2023-36.
doi: 10.1007/s00432-015-1982-6. Epub 2015 May 16.
Affiliations
- PMID: 25982455
- DOI: 10.1007/s00432-015-1982-6
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse
Lamprini Stamati et al. J Cancer Res Clin Oncol. 2015 Nov.
Abstract
Purpose: The identification of childhood acute lymphoblastic leukemia (ch-ALL) patients who are at a higher risk of chemotherapy resistance and relapse is essential for successful treatment decisions, despite the application of novel therapies. The aim of the study is the evaluation of BCL2 and BAX expression for the prognosis of ch-ALL patients treated with Berlin-Frankfurt-Münster (BFM) backbone protocol.
Methods: Bone marrow specimens were obtained at the time of diagnosis and on day 33 following BFM treatment induction from 82 ch-ALL patients, as well as from 63 healthy children. Following extraction, total RNA was reverse transcribed and BCL2 and BAX expression levels were determined by qPCR.
Results: BCL2 expression and BCL2/BAX ratio were strongly upregulated in ch-ALL compared to healthy children and were correlated with favorable prognostic disease features. Increased levels of BCL2 and BAX expression were associated with disease remission, as ch-ALL patients with lower expression ran a significantly higher risk of M2-M3 response, positive MRD and poor survival outcome. Moreover, the upregulation of BCL2 and BAX following BFM treatment induction was shown to represent an independent predictor of patients' short-term relapse, which was further confirmed in ch-ALL patients with favorable prognostic markers.
Conclusions: In conclusion, BCL2 and BAX could be effectively used for an enhanced prediction of BFM-treated patients' outcome.
Keywords: Apoptosis; Berlin–Frankfurt–Münster treatment protocol; Chemotherapy resistance; Childhood acute lymphoblastic leukemia (ch-ALL); Molecular tumor markers.
Similar articles
-
Piatopoulou D, Avgeris M, Drakaki I, Marmarinos A, Xagorari M, Baka M, Pourtsidis A, Kossiva L, Gourgiotis D, Scorilas A. Piatopoulou D, et al. Ann Hematol. 2018 Jul;97(7):1169-1182. doi: 10.1007/s00277-018-3292-y. Epub 2018 Mar 20. Ann Hematol. 2018. PMID: 29556721
-
Avgeris M, Stamati L, Kontos CK, Piatopoulou D, Marmarinos A, Xagorari M, Baka M, Doganis D, Anastasiou T, Kosmidis H, Gourgiotis D, Scorilas A. Avgeris M, et al. Clin Chem Lab Med. 2018 Nov 27;56(12):2104-2118. doi: 10.1515/cclm-2018-0507. Clin Chem Lab Med. 2018. PMID: 30016275
-
Piatopoulou D, Avgeris M, Marmarinos A, Xagorari M, Baka M, Doganis D, Kossiva L, Scorilas A, Gourgiotis D. Piatopoulou D, et al. Br J Cancer. 2017 Sep 5;117(6):801-812. doi: 10.1038/bjc.2017.256. Epub 2017 Aug 8. Br J Cancer. 2017. PMID: 28787435 Free PMC article.
-
Treatment and biology of pediatric acute lymphoblastic leukemia.
Kato M, Manabe A. Kato M, et al. Pediatr Int. 2018 Jan;60(1):4-12. doi: 10.1111/ped.13457. Pediatr Int. 2018. PMID: 29143423 Review.
-
Role of BAX for outcome prediction in gastrointestinal malignancies.
Pietrantonio F, Biondani P, Ciurlia E, Fanetti G, Tessari A, Bertarelli G, Bossi I, Musella V, Melotti F, Di Bartolomeo M, Valvo F, Pellegrinelli A, Milione M, Perrone F, de Braud F. Pietrantonio F, et al. Med Oncol. 2013;30(3):610. doi: 10.1007/s12032-013-0610-z. Epub 2013 May 23. Med Oncol. 2013. PMID: 23700226 Review.
Cited by
-
Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer.
Diamantopoulos MA, Tsiakanikas P, Scorilas A. Diamantopoulos MA, et al. Ann Transl Med. 2018 Jun;6(12):241. doi: 10.21037/atm.2018.06.10. Ann Transl Med. 2018. PMID: 30069443 Free PMC article. Review.
-
Kourtis A, Adamopoulos PG, Papalois A, Iliopoulos DC, Babis GC, Scorilas A. Kourtis A, et al. Ann Transl Med. 2018 Jun;6(12):243. doi: 10.21037/atm.2018.05.47. Ann Transl Med. 2018. PMID: 30069445 Free PMC article.
-
Alterations of Mitochondria and Related Metabolic Pathways in Leukemia: A Narrative Review.
Al Ageeli E. Al Ageeli E. Saudi J Med Med Sci. 2020 Jan-Apr;8(1):3-11. doi: 10.4103/sjmms.sjmms_112_18. Epub 2019 Dec 23. Saudi J Med Med Sci. 2020. PMID: 31929772 Free PMC article. Review.
-
Yi YJ, Jia XH, Wang JY, Chen JR, Wang H, Li YJ. Yi YJ, et al. Oncol Lett. 2018 May;15(5):7383-7388. doi: 10.3892/ol.2018.8229. Epub 2018 Mar 12. Oncol Lett. 2018. PMID: 29731890 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous